nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Alterations in the expression of homologous recombination repair (HRR) genes in breast cancer tissues considering germline BRCA1/2 mutation status
|
Laczmanska, Izabela |
|
|
208 |
3 |
p. 501-510 |
artikel |
2 |
A randomised trial comparing 6-monthly adjuvant zoledronate with a single one-time dose in patients with early breast cancer
|
Awan, Arif Ali |
|
|
208 |
3 |
p. 523-533 |
artikel |
3 |
Clinical and sociodemographic determinants of older breast cancer survivors’ reports of receiving advice about exercise
|
Wojcik, Kaitlyn M. |
|
|
208 |
3 |
p. 643-655 |
artikel |
4 |
Correction: FBLN2 is associated with basal cell markers Krt14 and ITGB1 in mouse mammary epithelial cells and has a preferential expression in molecular subtypes of human breast cancer
|
WalyEldeen, Amr Ahmed |
|
|
208 |
3 |
p. 687 |
artikel |
5 |
Cost containment analysis of superparamagnetic iron oxide (SPIO) injection in patients with ductal carcinoma in situ
|
Solís, Odette |
|
|
208 |
3 |
p. 565-568 |
artikel |
6 |
Cytokine levels in breast cancer are highly dependent on cytomegalovirus (CMV) status
|
Spencer, Juliet V. |
|
|
208 |
3 |
p. 631-641 |
artikel |
7 |
Effect of minocycline on changes in affective behaviors, cognitive function, and inflammation in breast cancer survivors undergoing chemotherapy: a pilot randomized controlled trial
|
Melink, Zihan |
|
|
208 |
3 |
p. 605-617 |
artikel |
8 |
Efficacy of antiobesity medications among breast cancer survivors taking aromatase inhibitors
|
Fansa, Sima |
|
|
208 |
3 |
p. 553-563 |
artikel |
9 |
Efficacy of everolimus plus hormonal treatment after cyclin-dependent kinase inhibitor; real-life experience, A TOG study
|
Beypınar, İsmail |
|
|
208 |
3 |
p. 597-604 |
artikel |
10 |
Endocrine therapy initiation among women diagnosed with ductal carcinoma in situ from 2001 to 2018
|
Bowles, Erin J. Aiello |
|
|
208 |
3 |
p. 577-587 |
artikel |
11 |
FBLN2 is associated with basal cell markers Krt14 and ITGB1 in mouse mammary epithelial cells and has a preferential expression in molecular subtypes of human breast cancer
|
WalyEldeen, Amr Ahmed |
|
|
208 |
3 |
p. 673-686 |
artikel |
12 |
Fragmentation of care in breast cancer: greater than the sum of its parts
|
Freeman, Hadley D. |
|
|
208 |
3 |
p. 511-521 |
artikel |
13 |
Is axillary web syndrome a risk factor for breast cancer-related lymphedema of the upper extremity? A systematic review and meta-analysis
|
Brunelle, Cheryl L. |
|
|
208 |
3 |
p. 471-490 |
artikel |
14 |
Letter to the editor: “Frequency of zoledronate administration in early breast cancer”
|
Tang, Wei-Zhen |
|
|
208 |
3 |
p. 689-690 |
artikel |
15 |
Microcalcifications in benign breast biopsies: association with lesion type and risk
|
Schrup, Sarah |
|
|
208 |
3 |
p. 543-551 |
artikel |
16 |
Oral minoxidil for late alopecia in cancer survivors
|
Kuo, Alyce Mei-Shiuan |
|
|
208 |
3 |
p. 491-499 |
artikel |
17 |
Patient characteristics and treatment patterns of patients with locally advanced or metastatic HER2-low breast cancer, a single site descriptive study
|
Willis, Connor |
|
|
208 |
3 |
p. 619-630 |
artikel |
18 |
Phenotypes of carriers of two mutated alleles in major cancer susceptibility genes
|
Laitman, Yael |
|
|
208 |
3 |
p. 589-595 |
artikel |
19 |
Phosphoenolpyruvate carboxykinase-2 (PCK2) is a therapeutic target in triple-negative breast cancer
|
Gunasekharan, Vignesh |
|
|
208 |
3 |
p. 657-671 |
artikel |
20 |
Polycystic ovary syndrome and risk of breast cancer in premenopausal and postmenopausal women: a nationwide population-based cohort study
|
Frandsen, Clarissa L. B. |
|
|
208 |
3 |
p. 535-542 |
artikel |
21 |
Tumor-infiltrating lymphocytes as a prognostic biomarker in patients with ductal carcinoma in situ of the breast: Correspondence
|
Daungsupawong, Hinpetch |
|
|
208 |
3 |
p. 691-692 |
artikel |
22 |
Variation in surgical treatment by body mass index in patients with invasive lobular carcinoma of the breast
|
Falade, Israel O. |
|
|
208 |
3 |
p. 569-575 |
artikel |